Pathogenesis of the vascular and glomerular damage in ANCA-positive vasculitis.

PubWeight™: 1.28‹?› | Rank: Top 10%

🔗 View Article (PMID 9507492)

Published in Nephrol Dial Transplant on January 01, 1998

Authors

J C Jennette1, R J Falk

Author Affiliations

1: School of Medicine, University of North Carolina at Chapel Hill 27599-7525, USA.

Articles citing this

Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest (2002) 5.42

The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies. Am J Pathol (2005) 1.97

Target antigens for anti-neutrophil cytoplasmic autoantibodies (ANCA) are on the surface of primed and apoptotic but not unstimulated neutrophils. Clin Exp Immunol (2000) 1.04

Anti-neutrophil cytoplasmic (ANCA) and anti-glomerular basement membrane (GBM) autoantibodies in necrotizing and crescentic glomerulonephritis. Semin Immunopathol (2007) 1.01

Immune and inflammatory role in renal disease. Compr Physiol (2013) 0.97

Dual myeloperoxidase-antineutrophil cytoplasmic antibody- and antiglomerular basement membrane antibody-positive cases associated with prior pulmonary fibrosis: a report of four cases. Clin Exp Nephrol (2011) 0.88

Neutrophils: game changers in glomerulonephritis? Trends Mol Med (2010) 0.86

Pro: Should all patients with anti-neutrophil cytoplasmic antibody-associated vasculitis be primarily treated with rituximab? Nephrol Dial Transplant (2015) 0.84

Granulocyte-macrophage colony-stimulating factor (GM-CSF) but not granulocyte colony-stimulating factor (G-CSF) induces plasma membrane expression of proteinase 3 (PR3) on neutrophils in vitro. Clin Exp Immunol (2000) 0.82

Inflammatory cells and cellular activation in the lower respiratory tract in Churg-Strauss syndrome. Thorax (1999) 0.79

What you should know about PR3-ANCA. Conformational requirements of proteinase 3 (PR3) for enzymatic activity and recognition by PR3-ANCA. Arthritis Res (2000) 0.79

Microscopic polyangitis complicating double carcinoma of the stomach and duodenum: improvement after the resection of these carcinomas. Rheumatol Int (2009) 0.78

False-positive myeloperoxidase binding activity due to DNA/anti-DNA antibody complexes: a source for analytical error in serologic evaluation of anti-neutrophil cytoplasmic autoantibodies. Clin Exp Immunol (2000) 0.77

Estimation of BVAS in patients with microscopic polyangiitis in Japan. Clin Rheumatol (2011) 0.75

Theodore E. Woodward Award. Do ANCA cause small vessel vasculitis? Trans Am Clin Climatol Assoc (2001) 0.75

Neutrophil extracellular traps in neuropathy with anti-neutrophil cytoplasmic autoantibody-associated microscopic polyangiitis. Clin Rheumatol (2017) 0.75

Eosinophils in Autoimmune Diseases. Front Immunol (2017) 0.75

Articles by these authors

(truncated to the top 100)

Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum (1994) 14.16

2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum (2013) 11.18

Small-vessel vasculitis. N Engl J Med (1997) 7.20

International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA) Am J Clin Pathol (1999) 3.31

Treatment of progressive membranous glomerulopathy. A randomized trial comparing cyclophosphamide and corticosteroids with corticosteroids alone. The Glomerular Disease Collaborative Network. Ann Intern Med (1992) 2.66

Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol (1989) 2.40

Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease. J Clin Invest (1983) 2.39

Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells. Kidney Int (1992) 2.30

Antibodies against granule proteins activate neutrophils in vitro. J Leukoc Biol (1991) 2.14

Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol (1996) 2.08

Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants. Kidney Int (2006) 2.06

Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol (1996) 1.95

Antineutrophil cytoplasmic autoantibodies and associated diseases: a review. Am J Kidney Dis (1990) 1.95

Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int (1994) 1.91

The pathologic spectrum of pulmonary lesions in patients with anti-neutrophil cytoplasmic autoantibodies specific for anti-proteinase 3 and anti-myeloperoxidase. Am J Clin Pathol (1995) 1.91

A review of therapeutic studies of idiopathic membranous glomerulopathy. Am J Kidney Dis (1995) 1.85

Leukocyte gene expression signatures in antineutrophil cytoplasmic autoantibody and lupus glomerulonephritis. Kidney Int (2007) 1.77

Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3. Blood (1990) 1.71

Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney Int (2000) 1.64

ANCA antigens, proteinase 3 and myeloperoxidase, are not expressed in endothelial cells. Kidney Int (2000) 1.53

Efficacy of treatment for unexplained infertility. Fertil Steril (1998) 1.48

Crosslinking of ANCA-antigens stimulates superoxide release by human neutrophils. J Am Soc Nephrol (1997) 1.40

Silica exposure in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and lupus nephritis. J Am Soc Nephrol (2001) 1.36

Interleukin-8 delays spontaneous and tumor necrosis factor-alpha-mediated apoptosis of human neutrophils. Kidney Int (1998) 1.34

Apoptosis of endothelial cells induced by the neutrophil serine proteases proteinase 3 and elastase. Am J Pathol (1996) 1.33

Localization of S protein and its relationship to the membrane attack complex of complement in renal tissue. Am J Pathol (1987) 1.33

Clinical and pathologic features of fibrillary glomerulonephritis. Kidney Int (1992) 1.32

Monoclonal antibodies to human renal basement membranes: heterogenic and ontogenic changes. Kidney Int (1983) 1.31

Reactivity of anti-neutrophil cytoplasmic autoantibodies with HL-60 cells. Clin Immunol Immunopathol (1989) 1.28

Radioimmunoassay of the attack complex of complement in serum from patients with systemic lupus erythematosus. N Engl J Med (1985) 1.26

Internalization of proteinase 3 is concomitant with endothelial cell apoptosis and internalization of myeloperoxidase with generation of intracellular oxidants. Am J Pathol (2001) 1.26

Infections associated with subclavian Uldall catheters. Arch Intern Med (1983) 1.21

Reactivity of antineutrophil cytoplasmic autoantibodies with mononuclear phagocytes. J Leukoc Biol (1992) 1.19

Lack of endothelial nitric oxide synthase aggravates murine accelerated anti-glomerular basement membrane glomerulonephritis. Am J Pathol (2000) 1.13

Adult minimal change glomerulopathy with acute renal failure. Am J Kidney Dis (1990) 1.11

Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: a systematic overview of randomized placebo-controlled trials. Am J Kidney Dis (2000) 1.08

Epidermolysis bullosa acquisita antigen, a major cutaneous basement membrane component, is synthesized by human dermal fibroblasts and other cutaneous tissues. J Invest Dermatol (1986) 1.05

Target antigens for anti-neutrophil cytoplasmic autoantibodies (ANCA) are on the surface of primed and apoptotic but not unstimulated neutrophils. Clin Exp Immunol (2000) 1.04

Diagnostic predictive value of ANCA serology. Kidney Int (1998) 1.04

Crescentic glomerulonephritis with a paucity of glomerular immunoglobulin localization. Am J Kidney Dis (1998) 1.03

Immune complex glomerulonephritis is induced in rats immunized with heterologous myeloperoxidase. Clin Exp Immunol (1994) 1.03

Restriction of the alternative pathway of human complement by intact Trypanosoma brucei subsp. gambiense. Infect Immun (1986) 1.02

Parvovirus B19 DNA in kidney tissue of patients with focal segmental glomerulosclerosis. Am J Kidney Dis (2000) 1.02

The pathogenic role of antineutrophil cytoplasmic autoantibodies. Am J Kidney Dis (1991) 1.02

The pathology of vasculitis involving the kidney. Am J Kidney Dis (1994) 1.01

Serum IgA-fibronectin aggregates in patients with IgA nephropathy and Henoch-Schönlein purpura: diagnostic value and pathogenic implications. The Glomerular Disease Collaborative Network. Am J Kidney Dis (1991) 1.01

Ultrastructural localization of the membrane attack complex of complement in human renal tissues. Am J Kidney Dis (1987) 1.01

Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in innervated kidneys in rats. Proc Natl Acad Sci U S A (1985) 0.97

Immune complex induced glomerular lesions in C5 sufficient and deficient mice. Kidney Int (1986) 0.96

Diagnostic classification of antineutrophil cytoplasmic autoantibody-associated vasculitides. Am J Kidney Dis (1991) 0.95

Antineutrophil cytoplasmic autoantibodies: disease associations, molecular biology, and pathophysiology. Int Rev Exp Pathol (1991) 0.94

Mycophenolate mofetil therapy in lupus nephritis: clinical observations. J Am Soc Nephrol (1999) 0.93

Diagnostic usefulness of antineutrophil cytoplasmic autoantibody serology. Comparative evaluation of commercial indirect fluorescent antibody kits and enzyme immunoassay kits. Am J Clin Pathol (1999) 0.93

The pathobiology of the terminal complement complexes. Complement Inflamm (1989) 0.93

Deposition of the membrane attack complex of complement in bullous pemphigoid. J Invest Dermatol (1984) 0.90

The life readiness program: a physical rehabilitation program for patients on hemodialysis. Am J Kidney Dis (2000) 0.90

Membrane attack complex of complement in dermatitis herpetiformis. Arch Dermatol (1985) 0.90

Synthesis of complement components C5, C6, C7, C8 and C9 in vitro by human monocytes and assembly of the terminal complement complex. Scand J Immunol (1986) 0.90

Reduced CD5(+) CD24(hi) CD38(hi) and interleukin-10(+) regulatory B cells in active anti-neutrophil cytoplasmic autoantibody-associated vasculitis permit increased circulating autoantibodies. Clin Exp Immunol (2015) 0.90

Increased red-cell sodium-lithium countertransport in normotensive sons of hypertensive parents. N Engl J Med (1982) 0.89

Clinical and pathological classification of ANCA-associated vasculitis: what are the controversies? Clin Exp Immunol (1995) 0.89

Cell populations and membrane attack complex in glomeruli of patients with post-streptococcal glomerulonephritis: identification using monoclonal antibodies by indirect immunofluorescence. Clin Immunol Immunopathol (1984) 0.89

Antineutrophil cytoplasmic autoantibody-positive crescentic glomerulonephritis as a complication of treatment with propylthiouracil in children. J Pediatr (1994) 0.89

Mapping of myeloperoxidase epitopes recognized by MPO-ANCA using human-mouse MPO chimers. Kidney Int (2006) 0.89

Microscopic polyangiitis (microscopic polyarteritis). Semin Diagn Pathol (2001) 0.89

Antimyeloperoxidase antibodies induce neutrophil adherence to cultured human endothelial cells. Ren Fail (1995) 0.89

The role of pathology in the diagnosis of systemic vasculitis. Clin Exp Rheumatol (2007) 0.86

Immunosuppressive therapy of lupus nephritis. Lupus (1998) 0.85

Difference in antigenic determinant profiles between human and rat myeloperoxidase. Clin Exp Immunol (2003) 0.85

Vitronectin: effects on keratinocyte motility and inhibition of collagen-induced motility. J Invest Dermatol (1991) 0.85

Monoclonal antibodies to the apical chloride channel in Necturus gallbladder inhibit the chloride conductance. Proc Natl Acad Sci U S A (1989) 0.85

Production of fibronectin by epithelium in a skin equivalent. J Invest Dermatol (1987) 0.84

Serum beta-human chorionic gonadotropin, estradiol and progesterone as early predictors of pathologic pregnancy. J Reprod Med (1992) 0.84

Site-specific activation of the alternative pathway of complement. Synthesis of a hybrid molecule consisting of antibody and cobra venom factor. Complement (1986) 0.84

Frequency of anti-bactericidal/permeability-increasing protein (BPI) and anti-azurocidin in patients with renal disease. Clin Exp Immunol (1996) 0.84

Antigens of the human glomerulus. Adv Nephrol Necker Hosp (1984) 0.83

Vasculitis affecting the skin. A review. Arch Dermatol (1994) 0.82

Amelioration of immune complex-mediated glomerulonephritis by synthetic protease inhibitors. Am J Pathol (1987) 0.82

Neutrophil superoxide release is required for spontaneous and FMLP-mediated but not for TNF alpha-mediated apoptosis. J Am Soc Nephrol (1997) 0.82

Shared idiotypy among patients with myeloperoxidase-anti-neutrophil cytoplasmic autoantibody associated glomerulonephritis and vasculitis. Lab Invest (1996) 0.81

Treatment of lupus nephritis--a work in progress. N Engl J Med (2000) 0.80

Restriction in V kappa gene use and antigen selection in anti-myeloperoxidase response in mice. J Immunol (2000) 0.80

Animal models in ANCA-vasculitis. Clin Exp Immunol (1995) 0.80

Diagnosis and management of glomerular diseases. Med Clin North Am (1997) 0.80

Do antineutrophil cytoplasmic autoantibodies cause Wegener's granulomatosis and other forms of necrotizing vasculitis? Rheum Dis Clin North Am (1993) 0.79

Do vasculitis categorization systems really matter? Curr Rheumatol Rep (2000) 0.79

Length of stay and costs for hospitalized hemodialysis patients: nephrologists versus internists. J Am Soc Nephrol (2000) 0.79

Epigenetics and complementary proteins. Clin Exp Immunol (2011) 0.78

Disease associations and pathogenic role of antineutrophil cytoplasmic autoantibodies in vasculitis. Curr Opin Rheumatol (1992) 0.78

Pathogenic potential of anti-neutrophil cytoplasmic autoantibodies. Adv Exp Med Biol (1993) 0.78

Immunoglobulin A-fibronectin aggregate levels in children and adults with immunoglobulin A nephropathy. Am J Kidney Dis (1993) 0.78

Ig-class specificity of ANCA. Neth J Med (1990) 0.78

Pathogenesis of vasculitis. Semin Neurol (1994) 0.78

Goodpasture's syndrome revisited. A new perspective on glomerulonephritis and alveolar hemorrhage. N C Med J (1990) 0.77

The clinical, serologic, and immunopathologic heterogeneity of cutaneous leukocytoclastic angiitis. Adv Exp Med Biol (1993) 0.77

Estrogen and progesterone regulation of carbonic anhydrase isoenzymes in guinea pig and rabbit uterus. Endocrinology (1971) 0.77

Uptake of tritiated progesterone by the uterus of the ovariectomized guinea pig. Endocrinology (1970) 0.77

Reconstitution of an epithelial chloride channel. Conservation of the channel from mudpuppy to man. J Gen Physiol (1991) 0.77

Antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Clin Pathol (1993) 0.77

False-positive myeloperoxidase binding activity due to DNA/anti-DNA antibody complexes: a source for analytical error in serologic evaluation of anti-neutrophil cytoplasmic autoantibodies. Clin Exp Immunol (2000) 0.77